TMEM97 and cancer: This strategy, which led to potent cytotoxic TSCs, was based on the efficacy of some sigma-2 receptor ligands against highly aggressive tumors [8, 11–14] and on the sensitivity of cancer cells to changes in energy levels and needs [2].